Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other financing activities (2016 - 2018)

Assembly Biosciences (ASMB) has 4 years of Other financing activities data on record, last reported at -$543780.0 in Q3 2018.

  • For Q3 2018, Other financing activities fell 451.84% year-over-year to -$543780.0; the TTM value through Sep 2018 reached -$524726.0, down 138.03%, while the annual FY2017 figure was -$84192.0, 44.64% down from the prior year.
  • Other financing activities reached -$543780.0 in Q3 2018 per ASMB's latest filing, down from $18857.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $86231.0 in Q4 2017 and bottomed at -$543780.0 in Q3 2018.
  • Average Other financing activities over 4 years is -$63494.7, with a median of -$27032.0 recorded in 2015.
  • Peak YoY movement for Other financing activities: surged 293.32% in 2017, then plummeted 724.97% in 2018.
  • A 4-year view of Other financing activities shows it stood at -$27032.0 in 2015, then crashed by 85.05% to -$50022.0 in 2016, then skyrocketed by 272.39% to $86231.0 in 2017, then crashed by 730.61% to -$543780.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Other financing activities were -$543780.0 in Q3 2018, $18857.0 in Q2 2018, and -$86034.0 in Q1 2018.